US health agency questions the robustness of data from the AstraZeneca COVID-19 vaccine trial
(Reuters) – AstraZeneca Plc may have provided an incomplete view of the effectiveness data for its COVID-19 vaccine from a large-scale US trial, a U.S. health agency said on Tuesday in a new …
